|
|
Volumn 66, Issue 18, 2009, Pages 1596-
|
|
Asenapine approved for treatment of schizophrenia, bipolar disorder
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ASENAPINE;
BIPOLAR DISORDER;
CEREBROVASCULAR ACCIDENT;
CLINICAL TRIAL;
DEMENTIA;
DIABETES MELLITUS;
DISEASE ASSOCIATION;
DROWSINESS;
DRUG EFFICACY;
DRUG WITHDRAWAL;
HUMAN;
HYPERGLYCEMIA;
MOTOR DYSFUNCTION;
NEUROLEPTIC MALIGNANT SYNDROME;
NOTE;
ORTHOSTATIC HYPERTENSION;
PRIORITY JOURNAL;
PSYCHOSIS;
RESTLESSNESS;
SCHIZOPHRENIA;
SIDE EFFECT;
TARDIVE DYSKINESIA;
TASTE ACUITY;
TRANSIENT ISCHEMIC ATTACK;
WEIGHT GAIN;
|
|
EID: 70349310525
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.2146/news090073 Document Type: Note |
|
Times cited : (4)
|
|
References (0)
|